Why Moderna Shares Tripped on Tuesday
Moderna (NASDAQ: MRNA), considered by some to be the leader of the pack of coronavirus stocks at the moment, fell by 3.9% Tuesday on what was generally an up day for the broader stock market.
The most likely reason for this is the pronouncement of a Chinese pharmaceutical company, Sinopharm, which on Tuesday set a price range for its two COVID-19 vaccine candidates.
Image source: Getty Images.
Source Fool.com


